Temomedac
Active substance: temozolomide
temozolomide
Centralised EU authorisationActive
Marketing holder: medac Gesellschaft für klinische Spezialpräparate mbH
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 37 |
|
| US 71 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-2e26-70b3-98f2-45ffca3fee13,01a120c3-2e40-7ab5-8d3b-8044284fc3a3,01a120c3-410d-7206-acd2-87cceee6b70e,01a120c3-6f2f-79ad-9190-c75b13752155,01a120c3-7004-76fa-9193-fc9e2bb85dc7;count=28 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-29aa-7368-8e0d-33acac3a7799,01a1208c-2e8f-7997-b7ad-627f72040447,01a1208c-305f-7779-9449-71bd7bf6a3a7,01a1208c-36a5-78c8-b666-df4e9ba769c6,01a1208c-4ae4-7a21-bdb4-4864d124851c;count=71 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- EMEA/H/C/001124
- Registration status
- Active
- ATC code
- L01AX03
- product · EMA · EMEA/H/C/001124 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/001124 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/001124 · Verified 2026-10-09